Standard GLP-1 prescriptions follow a "one-size-fits-all" schedule, increasing your dosage from a standard dosage until a maximum maintenance dosage
The pharmaceutical industry's evolution in obesity therapeutics has progressed from single-target approaches (pure GLP-1 agonists like semaglutide) to dual agonists (GLP-1/GIP like tirzepatide), and now to triple agonists like retatrutide that attempt to orchestrate an even more comprehensive metabolic remodeling by simultaneously modulating multiple complementary pathways
A comprehensive investigation through longitudinal studies encompassing rigorous assessment of psychiatric history and medication response profiles will help inform clinical decision-making and optimize patient care
Hydration needs should be individualized based on activity level, climate, concurrent medical conditions, and thirst
Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, et al
They mimic the hormone GLP-1, which slows down stomach emptying to reduce hunger and control blood sugar